<DOC>
	<DOCNO>NCT01056328</DOCNO>
	<brief_summary>The purpose study test safety effectiveness Irrigated Ablation System treatment symptomatic paroxysmal atrial fibrillation .</brief_summary>
	<brief_title>Irrigated Ablation System Evaluation Atrial Fibrillation ( AF )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Age 18 year old Signed Patient Informed Consent Form Able willing comply pre , post , followup testing requirement Failure least one antiarrhythmic medication ( AAD ) paroxysmal atrial fibrillation* [ class I III , AV nodal block agent beta blocker ( BB ) calcium channel blocker ( CCB ) ] evidence recurrent symptomatic paroxysmal atrial fibrillation* , intolerable side effect due AAD Subjects symptomatic paroxysmal atrial fibrillation ( PAF ) * PAF define recurrent atrial fibrillation ( AF ) terminate spontaneously within seven day . Atrial fibrillation ( AF ) secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause Previous ablation AF History valvular cardiac surgical procedure Coronary artery bypass grafting ( CABG ) procedure within last six month Awaiting cardiac transplantation cardiac surgery within next 12 month Left atrial thrombus History document thromboembolic event within past one ( 1 ) year Diagnosed atrial myxoma An implant implantable cardioverter defibrillator ( ICD ) Significant pulmonary disease , ( e.g . restrictive pulmonary disease , constrictive chronic obstructive pulmonary disease ) disease malfunction lungs respiratory system produce chronic symptom Significant congenital anomaly medical problem opinion investigator would preclude enrollment study Women pregnant ( history menstrual period pregnancy test history consider unreliable ) Acute illness active systemic infection sepsis Unstable angina Myocardial infarction within previous two month Left ventricular ejection fraction ( LVEF ) &lt; 40 % determined preprocedure transthoracic echocardiogram ( TTE ) History blood clot bleed abnormality Contraindication anticoagulation ( i.e . heparin warfarin ) Contraindication compute tomography/magnetic resonance angiography ( CT/MRA ) procedure Life expectancy le 12 month Enrollment investigational study evaluate another device drug Uncontrolled heart failure New York Heart Association ( NYHA ) class III IV heart failure An intramural thrombus tumor , abnormality precludes catheter introduction manipulation Presence condition precludes vascular access Left atrial size â‰¥ 50 mm determine preprocedure TTE</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>